株式会社カワチ薬品 通期業績予想及び配当予想の修正

This document is a notification from Kawachi Pharmaceutical Co., Ltd. regarding the revision of the full-year earnings forecast and dividend forecast announced on October 29, 2025. The earnings forecast for the fiscal year ending March 2026 is expected to fall short of the plan due to rising prices, declining consumer sentiment, and increased competition. As a result, the full-year earnings forecast has been revised, and the year-end dividend forecast has also been adjusted. The annual dividend will be set at 100 yen, consisting of an ordinary dividend of 80 yen and a commemorative dividend of 20 yen for the company's 65th anniversary. The company emphasizes shareholder returns and aims for stable growth.